Castle Biosciences Inc (CSTL)
24.33
+1.49
(+6.52%)
USD |
NASDAQ |
May 03, 16:00
24.28
-0.05
(-0.21%)
After-Hours: 20:00
Castle Biosciences Enterprise Value: 442.47M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 442.47M |
May 02, 2024 | 401.34M |
May 01, 2024 | 378.70M |
April 30, 2024 | 353.02M |
April 29, 2024 | 365.17M |
April 26, 2024 | 332.32M |
April 25, 2024 | 309.40M |
April 24, 2024 | 318.67M |
April 23, 2024 | 324.18M |
April 22, 2024 | 311.77M |
April 19, 2024 | 303.49M |
April 18, 2024 | 300.46M |
April 17, 2024 | 290.53M |
April 16, 2024 | 293.29M |
April 15, 2024 | 301.29M |
April 12, 2024 | 324.18M |
April 11, 2024 | 344.05M |
April 10, 2024 | 334.39M |
April 09, 2024 | 365.01M |
April 08, 2024 | 346.25M |
April 05, 2024 | 345.15M |
April 04, 2024 | 356.74M |
April 03, 2024 | 364.74M |
April 02, 2024 | 383.22M |
April 01, 2024 | 384.57M |
Date | Value |
---|---|
March 31, 2024 | 381.81M |
March 28, 2024 | 364.92M |
March 27, 2024 | 341.04M |
March 26, 2024 | 349.55M |
March 25, 2024 | 328.41M |
March 22, 2024 | 313.31M |
March 21, 2024 | 336.10M |
March 20, 2024 | 315.51M |
March 19, 2024 | 288.33M |
March 18, 2024 | 276.94M |
March 15, 2024 | 274.33M |
March 14, 2024 | 286.69M |
March 13, 2024 | 302.06M |
March 12, 2024 | 304.80M |
March 11, 2024 | 307.27M |
March 08, 2024 | 327.59M |
March 07, 2024 | 326.49M |
March 06, 2024 | 345.98M |
March 05, 2024 | 369.31M |
March 04, 2024 | 339.66M |
March 01, 2024 | 304.25M |
February 29, 2024 | 252.65M |
February 28, 2024 | 426.41M |
February 27, 2024 | 445.62M |
February 26, 2024 | 429.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
79.17M
Minimum
Jun 05 2023
2.005B
Maximum
Feb 09 2021
621.01M
Average
444.66M
Median
Feb 03 2020
Enterprise Value Benchmarks
Exact Sciences Corp | 12.85B |
Illumina Inc | 19.17B |
Mettler-Toledo International Inc | 28.90B |
Waters Corp | 21.01B |
Natera Inc | 11.34B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.534M |
Revenue (Quarterly) | 72.97M |
Total Expenses (Quarterly) | 78.44M |
EPS Diluted (Quarterly) | -0.09 |
Gross Profit Margin (Quarterly) | 80.96% |
Profit Margin (Quarterly) | -3.47% |
Earnings Yield | -4.69% |
Normalized Earnings Yield | -4.686 |